Background
It is expected that MSCT will be used increasingly as an alternative imaging modality in the diagnosis of patients with suspected CAD. Data on the prognostic value of MSCT, however, are currently not available.
Methods
A total of 100 patients (73 men, age 59 Ϯ 12 years) who were referred for further cardiac evaluation due to suspicion of significant CAD underwent additional MSCT coronary angiography to evaluate the presence and severity of CAD. Patients were followed up for the occurrence of: 1) cardiac death, 2) nonfatal myocardial infarction, 3) unstable angina requiring hospitalization, and 4) revascularization.
Results
Coronary plaques were detected in 80 (80%) patients. During a mean follow-up of 16 months, 33 events occurred in 26 patients. In patients with normal coronary arteries on MSCT, the first-year event rate was 0% versus 30% in patients with any evidence of CAD on MSCT. The observed event rate was highest in the presence of obstructive lesions (63%) and when obstructive lesions were located in the left main (LM)/left anterior descending (LAD) coronary arteries (77%). Nonetheless, an elevated event rate was also observed in patients with nonobstructive CAD (8%). In multivariate analysis, significant predictors of events were the presence of CAD, obstructive CAD, obstructive CAD in LM/LAD, number of segments with plaques, number of segments with obstructive plaques, and number of segments with mixed plaques.
Conclusions
Multislice computed tomography coronary angiography provides independent prognostic information over baseline clinical risk factors in patients with known and suspected CAD. An excellent prognosis was noted in patients with a normal MSCT. In patients presenting with suspected or known coronary artery disease (CAD), assessment of prognosis is essential in selecting appropriate patient management. Currently, extensive data are available on the prognostic value of myocardial perfusion imaging with single-photon emission computed tomography (SPECT). A normal SPECT study has been shown to indicate a good clinical outcome with an annual death or infarct rate of Ͻ1% per year, whereas the likelihood to develop cardiac events is significantly increased when perfusion abnormalities are detected (1, 2) . Similarly, coronary artery calcium score assessed by electron beam computed tomography (EBCT) or, less frequently, by multislice computed tomography (MSCT), has been used for risk stratification in patients with known or suspected CAD, and a calcium score Ͻ100 has been associated with excellent outcome, with an increase in the event rate paralleling the increase in calcium score (3, 4) .
More recently, noninvasive coronary angiography techniques (magnetic resonance imaging, EBCT, and MSCT) have been introduced which allow direct visualization of coronary artery lesions. At present, MSCT appears to be the most robust technique for this purpose, and it is expected that this technique will be increasingly used as an alternative first-line imaging modality in the diagnosis of patients presenting with chest pain suspect for CAD. Multislice computed tomography allows detection of both obstructive and nonobstructive lesions, and noncalcified lesions are also visualized. Although the diagnostic accuracy of MSCT has been demonstrated, data on the prognostic value of MSCT are not available. Accordingly, the aim of this study was to determine the prognostic value of MSCT in patients with known or suspected CAD.
Methods
Patients and study protocol. The study population consisted of consecutive patients who presented to the outpatient clinic and were referred for further evaluation (using exercise electrocardiogram, perfusion imaging, or invasive coronary angiography) of suspected CAD (chest pain complaints, elevated risk profile, or abnormal test results). In all patients, MSCT coronary angiography was performed in addition to the standard clinical workup. Subsequent clinical management was based on the latter; MSCT findings were not included in the diagnostic/therapeutic workup.
Only patients without previous coronary bypass grafting who were in sinus rhythm and without contraindications to iodinated contrast media were included, resulting in the exclusion of 5 patients because of potential contrast allergy (n ϭ 3) and atrial fibrillation (n ϭ 2), respectively. Follow-up was successful in all patients. All patients gave written informed consent to the study protocol, which was approved by the local ethics committee.
A structured interview and clinical history were acquired, and the following cardiac risk factors were assessed before the MSCT examination: 1) diabetes mellitus (defined as a fasting glucose level of Ն7 mmol/l or the need for insulin or oral hypoglycemic agents) (5); 2) hypercholesterolemia (defined as a total cholesterol level Ն5 mmol/l or treatment with lipid-lowering drugs) (6); 3) hypertension (defined as blood pressure Ն140/90 mm Hg or the use of antihypertensive medication) (7); 4) obesity (body mass index Ն30 kg/m 2 ) (8); 5) positive family history of CAD (defined as the presence of CAD in first-degree relatives younger than 55 [male] or 65 [female] years of age) (9); and 6) smoking (defined as previous or current smoking). MSCT data acquisition. All examinations were performed using Toshiba Multislice Aquilion systems (Toshiba Medical Systems, Tokyo, Japan). If the heart rate was Ն65 beats/min, additional oral beta-blockers (metoprolol, 50 mg, single dose, 1 h before scan) were provided if tolerated. First, a prospectively triggered coronary calcium scan was performed before MSCT angiography with identical parameters for 16-and 64-slice MSCT systems: collimation 4 ϫ 3.0 mm, gantry rotation time 500 ms, tube voltage and tube current 120 kV and 200 mA, respectively. The temporal window was set at 75% after the R-wave for electrocardiographically triggered prospective reconstruction.
Sixteen-slice MSCT coronary angiography was performed according to the protocol described elsewhere (10) . The following parameters were applied for 64-slice MSCT coronary angiography: collimation of 64 ϫ 0.5 mm; tube rotation time of 400, 450, or 500 ms, depending on the heart rate; tube current 300 mA at 120 kV. Nonionic contrast material was administered in the antecubital vein with an amount of 80 to 105 ml, depending on the total scan time, and a flow rate of 5 ml/s (Iomeron 400, Bracco Altana Pharma, Konstanz, Germany). Automated detection of peak enhancement in the aortic root was used for timing of the scan. All images were acquired during an inspiratory breath hold of approximately 10 s, with simultaneous registration of the patient's electrocardiogram. With the aid of a segmental reconstruction algorithm, data of 1, 2, or 3 consecutive heartbeats were used to generate a single image.
To evaluate the presence of coronary artery plaques, reconstructions in diastole (typically 75% of the cardiac cycle) were generated with a slice thickness of 0.5 mm at an increment of 0.3 mm. If motion artefacts were present, additional reconstructions were made in different time points of the R-R interval. Axial data sets were transferred to a remote workstation (Vitrea 2, Vital Images, Plymouth, Minnesota) for postprocessing and subsequent evaluation.
MSCT data analysis. CORONARY ARTERY CALCIUM SCORE.
The coronary artery calcium score was assessed with the application of dedicated software (Vitrea 2). Coronary artery calcium was identified as a dense area in the coronary artery exceeding the threshold of 130 HU. An overall Agatston score was recorded for each patient.
CORONARY PLAQUE ASSESSMENT. For the current study, all MSCT angiograms were evaluated within a time frame of 2 weeks by 2 experienced observers unaware of the clinical history of the patients, using a standard analysis (see later text). In case of disagreement, a joint reading was performed and a consensus decision was reached. Coronary arteries were divided into 17 segments according to the modified American Heart Association classification (11) . Only segments with a diameter Ͼ1.5 mm (as measured on the MSCT coronary angiogram) were included. First, each segment was classified as interpretable or not. Predefined, patients were excluded from the analysis in case of: 1) an uninterpretable proximal or mid segment, or 2) more than 3 uninterpretable segments in general.
Then, the interpretable segments were evaluated for the presence of any atherosclerotic plaque using axial images and curved multiplanar reconstructions. Coronary plaques were defined as structures Ͼ1 mm 2 within and/or adjacent and hard cardiac events (cardiac death, nonfatal infarction, and unstable angina requiring hospitalization) were compared using the log-rank test.
Statistical analyses were performed using SPSS software (version 12.0, SPSS Inc., Chicago, Illinois) and SAS software (version 6.12, SAS Institute Inc., Cary, North Carolina), and p values Ͻ 0.05 were considered statistically significant.
Results

Patient characteristics.
In total, 104 consecutive patients were enrolled in the present study. In 4 patients, an elevated and/or irregular heart rate during MSCT data acquisition rendered the MSCT data set uninterpretable, and these patients were excluded from the analysis. As a result, 100 patients (73 men, mean age 59 Ϯ 12 years) were included in the study (15 patients were included in a previous study on the diagnostic accuracy of MSCT in direct comparison with invasive angiography [10] ). Baseline characteristics are provided in Table 1 . Briefly, 65 patients (65%) presented with suspected CAD at the time of MSCT, whereas CAD was known in the remaining 35 patients (35%) (33 patients had previous myocardial infarction, 31 patients had previous percutaneous coronary intervention). In total, 55 patients underwent 16-slice MSCT and 45 underwent 64-slice MSCT.
MSCT Characteristics of the Study Population and Comparison Between Patients With and Without Events
MSCT. The MSCT characteristics are provided in Table  2 . Only coronary segments with sufficient lumen diameter for evaluation of the presence of plaques were included in the analysis. After exclusion of 33 (2%) coronary segments with stents and 19 (1%) nonevaluable segments because of motion artifacts, plaque burden was evaluated in 1,298 segments. CAD was completely absent in 20 patients. In the remaining 80 patients, 345 coronary segments with plaques were observed, of which 47 (14%) contained noncalcified plaques, 109 (31%) mixed plaques, and 189 (55%) calcified plaques. In 71 (21%) segments of 32 (32%) patients, plaques were regarded as obstructive (Ն50% luminal narrowing). Thirty-two (9%) segments with obstructive lesions in 23 (23%) patients were located in the LM and/or LAD coronary artery. In Figure 1 , examples of different MSCT observations, including normal coronary arteries, nonobstructive CAD, and obstructive CAD in the LM, are shown. Follow-up results. During a mean follow-up of 16 months (median 13 months, interquartile range 5 to 39 months), 33 events occurred in 26 patients (with 7 events occurring repeatedly). One patient (1%) died of acute myocardial infarction. Nonfatal myocardial infarction occurred in 3 patients (3%), and unstable angina requiring hospitalization occurred in 4 patients (4%, with 1 also undergoing revascularization). A total of 24 patients (24%) underwent coronary revascularization; percutaneous coronary intervention was performed in 17 patients, whereas the remaining 7 patients underwent coronary artery bypass grafting. The decision for revascularization was based on worsening angina and/or the presence of ischemia on noninvasive testing. Predictors of events. Baseline and clinical characteristics of patients with and without events are described in Table 1 .
Patients presenting with events during follow-up were significantly older (p ϭ 0.03) and had worse clinical condition, as indicated by an elevated European System for Cardiac Operative Risk Evaluation value (p ϭ 0.01). No significant differences in risk factors for CAD and use of medication were observed. Differences in MSCT characteristics of patients with and without events are summarized in Table 2 . Patients with events had more extensive atherosclerosis on MSCT, as reflected by a higher coronary calcium score and a higher number of segments showing (obstructive) plaques. Also, relatively more mixed and calcified plaques were observed as compared with patients without events.
In Table 3 , the univariate analysis of both clinical and MSCT characteristics to predict events is summarized. In the multivariate analysis (Table 4) , MSCT characteristics that were significant during univariate analysis were corrected for baseline characteristics with p Յ 0.5 during univariate analysis, whereas the type of scanner (16-vs. 64-slice MSCT) used was also included in the analysis. As indicated in Table 4 , the remaining significant independent predictors of cardiac events in the multivariate analysis were the presence of coronary plaques, obstructive CAD, LM/ LAD disease, number of coronary segments with plaques, number of coronary segments with obstructive plaques, and number of coronary segments with mixed plaques. Tables 1 and 2 .
Univariate Predictors of Events
Multivariate Predictors of Events, Corrected for Baseline Variables Tables 1 and 3 .
Survival analysis. Kaplan-Meier survival curves are provided in Figures 2 to 5. As can be derived from Figure 2 , no events occurred in patients with normal coronary arteries on MSCT, whereas a first-year event rate (including all events) of 30% was observed in patients with any CAD on MSCT (log-rank p value ϭ 0.005). Excluding revascularizations resulted in a first-year hard cardiac event rate of 5% in patients with CAD on MSCT, as compared with 0% in patients with completely absent CAD on MSCT (log-rank p value ϭ 0.19) (Fig. 3) . In Figure 4 , the relationship between the severity of CAD and the occurrence of events was further explored, showing an increased event rate in patients with obstructive CAD (63%) compared with patients without CAD (0%) or nonobstructive CAD (8%) (log-rank p value Ͻ0.001). Finally, LM/LAD disease was found to be associated with the highest event rate (77%), as shown in Figure 5 (log-rank p value Ͻ0.001).
Discussion
In the present study, MSCT coronary angiography provided independent prognostic information for predicting cardiac events. Patients with completely absent CAD on MSCT coronary angiography had an excellent prognosis (0% event rate), whereas an increased event rate (30%) was observed in patients with CAD on MSCT. Furthermore, the risk of cardiac events increased with the extent of CAD as observed on MSCT, and patients with obstructive lesions (particularly Pundziute et al. January 2/9, 2007:62- 70 Prognostic Value of MSCT Coronary Angiography in the LM and LAD) were shown to be at the greatest risk for cardiac events. Even after correction for baseline clinical variables such as age and risk factors, MSCT variables reflecting coronary plaque burden, including the severity, extent, and location of atherosclerosis, remained independent predictors of cardiac events. The prognostication and subsequent management of patients with known or suspected CAD in current practice relies on initial clinical evaluation, with the low-risk patients being reassured and the high-risk patients being referred for invasive angiography (14) . However, the majority of these patients are in the intermediate risk group, in whom prognosis and subsequent management is less well defined. Accordingly, these patients need additional testing with 1 or more of the established noninvasive modalities, which include exercise electrocardiography, stress SPECT imaging, or stress echocardiography (14) . All these techniques aim at detecting ischemia. Exercise electrocardiography is not an ideal modality because of the suboptimal accuracy, and imaging of stress-induced perfusion abnormalities or systolic wall motion abnormalities may be preferred; indeed, average sensitivity and specificity of 87% and 73% to detect CAD have been reported for SPECT versus 82% and 84% All events indicate cardiac death, nonfatal infarction, unstable angina requiring hospitalization, and revascularization. LAD ϭ left anterior descending coronary artery; LM ϭ left main coronary artery; other abbreviations as in Figure 4 .
